What laboratory studies are recommended for the workup of suspected hemolysis?

Hemolytic Laboratory Studies

The essential laboratory workup for suspected hemolysis includes: reticulocyte count, lactate dehydrogenase (LDH), haptoglobin, indirect (unconjugated) bilirubin, and peripheral blood smear examination. 1, 2, 1

Core Hemolysis Markers

The diagnosis of hemolysis relies on straightforward biochemical parameters that demonstrate red blood cell destruction:

• Haptoglobin (most sensitive marker) - decreased or undetectable 3
• Lactate dehydrogenase (LDH) - elevated 1, 2, 1
• Indirect (unconjugated) bilirubin - elevated, typically <5 mg/dL in chronic hemolysis 1
• Reticulocyte count - typically >120×10⁹/L (except in early acute hemolysis or with concurrent vitamin deficiency) 3

Important caveat: Haptoglobin is the most sensitive single marker for hemolysis 3. LDH elevation can occur from other sources (liver, lungs, muscle), so it should not be interpreted in isolation 4.

Complete Blood Count Parameters

The initial presentation of anemia plus thrombocytopenia should always prompt determination of hemolysis markers 5. Essential CBC components include:

• Hemoglobin/hematocrit - to assess degree of anemia 2
• Mean corpuscular volume (MCV) - helps classify anemia type 6
• Red cell distribution width (RDW) - elevated in hemolysis 6
• Platelet count - to evaluate for thrombotic microangiopathy 5

Peripheral Blood Smear

A peripheral blood smear is mandatory when hemolysis is present to identify abnormal red blood cell morphologies 7. Look for:

• Schistocytes - fragmented RBCs indicating microangiopathic hemolysis 8, 5
• Spherocytes, echinocytes - suggest membrane disorders 1
• Anisocytosis and poikilocytosis - general markers of RBC abnormalities 1

Note that in some hemolytic conditions (like pyruvate kinase deficiency), red cell morphology may be unremarkable 1.

Additional Hemolysis Markers

For more extensive workup or when initial tests are equivocal 6:

• Free hemoglobin (plasma) - >40 mg/dL indicates significant hemolysis 2, 4
• Direct antiglobulin test (DAT/Coombs test) - differentiates immune from non-immune hemolysis 2, 7
• Direct and indirect bilirubin - indirect fraction elevated in hemolysis 2

Critical Distinguishing Tests

Once hemolysis is confirmed, these tests help determine the specific cause 2:

• Direct antiglobulin test (Coombs) - should be negative in non-immune hemolysis 5, 3
• ADAMTS13 activity - must be checked urgently if thrombotic thrombocytopenic purpura (TTP) suspected; <10% confirms TTP 8, 5
• Paroxysmal nocturnal hemoglobinuria (PNH) screening by flow cytometry 2, 3
• Disseminated intravascular coagulation (DIC) panel - PT/INR to exclude DIC 2

Specialized Testing for Specific Etiologies

When initial workup doesn't reveal a cause 2, 3:

• Hemoglobin electrophoresis/phenotyping - for hemoglobinopathies 3
• Eosin-5'-maleimide (EMA) binding test - for hereditary spherocytosis 3
• G6PD enzyme assay - for glucose-6-phosphate dehydrogenase deficiency 2
• Red cell enzyme assays - for enzymopathies like pyruvate kinase deficiency 1
• Osmotic fragility - though not specific for most conditions 1

Common Pitfalls to Avoid

1. Don't rely on LDH alone - it can be elevated from non-hemolytic sources; always correlate with haptoglobin and bilirubin 4

2. Reticulocyte count may be falsely reassuring - can be inappropriately low in early acute hemolysis, with concurrent vitamin B12/folate deficiency, or in conditions with splenic sequestration 1, 3

3. Anemia is not always present - hemolysis can occur with normal hemoglobin if compensated 3

4. Sample timing matters - for ADAMTS13 testing, draw before plasma exchange if possible; if not, sample before the next session remains useful 8

5. In vitro hemolysis (specimen handling artifact) is indistinguishable from in vivo hemolysis on routine testing - clinical correlation is essential 9

Algorithmic Approach

Step 1: Confirm hemolysis with core markers (↓haptoglobin, ↑LDH, ↑indirect bilirubin, ↑reticulocytes)

Step 2: Perform peripheral smear and DAT to categorize as immune vs. non-immune

Step 3: If thrombocytopenia present, urgently check ADAMTS13 and consider thrombotic microangiopathy

Step 4: Based on smear findings and clinical context, pursue specific testing (hemoglobin electrophoresis, PNH flow cytometry, enzyme assays)

Step 5: If diagnosis remains unclear after extensive workup, consult hematology 6